You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 29 No. 5, November 1973 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Anxiety and β-Adrenergic Blockade

Walter N. Stone, MD; Goldine C. Gleser, PhD; Louis A. Gottschalk

Arch Gen Psychiatry. 1973;29(5):620-622.


Abstract



Twenty-four healthy male volunteers were given 60 mg of propranolol hydrochloride (a β-adrenergic blocking agent) or placebo in divided doses given orally during the 12 hours preceding experimental procedures. As a group those subjects receiving propranolol had significantly lower initial anxiety levels measured from speech samples. A stress interview was followed by increases in anxiety scores to comparable levels in both groups.

Plasma free fatty acid (FFA) determinations did not differ significantly for the two groups, either initially or during the experimental period. However, pulse rate at the end of the 55-minute session was significantly lower for subjects on propranolol. The correlation between anxiety scored from the initial speech sample and FFA level was positive and significant for the placebo subjects and negative for the propranolol group. Propranolol administered orally may have value as an antianxiety agent and in addition is seen as providing an avenue for the exploration of psychobiological relationships.



Author Affiliations



Cincinnati; Irvine, Calif

From the University of Cincinnati (Dr. Stone and Dr. Gleser) and the University of California, Irvine (Dr. Gottschalk).


Footnotes



Accepted for publication April 30, 1973.

Reprint requests to the Department of Psychiatry, Cincinnati General Hospital, University of Cincinnati, Cincinnati, OH 45229 (Dr. Stone).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Biphasic effects of propranolol on a temporal generalization gradient in the rat
Terry and Salmon
J Psychopharmacol 1990;4:63-68.
ABSTRACT  

Behavioral neurochemistry: neuroregulators and behavioral states
Barchas et al.
Science 1978;200:964-973.
ABSTRACT  

Beta-Adrenergic Receptor Blocking Drugs in Psychiatry
Jefferson
Arch Gen Psychiatry 1974;31:681-691.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.